Saundra Pelletier

Saundra Pelletier is the CEO of Evofem Biosciences, where she has successfully led the company through significant growth and its transition to the public market, raising over $500 million in equity financing. Under her leadership, Evofem launched Phexxi, the first hormone-free, on-demand prescription birth control approved in the U.S., and expanded its product offerings with the acquisition of So...